LAG3 in Cancer Immunotherapy

Monica V. Goldberg and Charles G. Drake

Contents

1 Structural Aspects of LAG-3 270

1.1 Basic Structure 270

1.2 LAG-3 Expression 270

1.3 Binding of Class II MHC 271

1.4 Localization of LAG-3 in T Cells 272

2 LAG-3 Function 272

2.1 Role in CD4 T Cell Function and Expansion 272

2.2 Role of LAG-3 on Regulatory T Cells 273

2.3 Role of LAG-3 on CD8 T Cells 273

2.4 LAG-3 Mechanism of Action 274

3 LAG-3 in Cancer Immunotherapy 275

3.1 Preclinical Studies 275

3.2 Clinical Studies 275

4 Conclusions 276

References 277

Abstract LAG-3 (CD223) is a cell surface molecule expressed on activated T cells (Huard et al. Immunogenetics 39:213-217, 1994), NK cells (Triebel et al. J Exp Med 171:1393-1405, 1990), B cells (Kisielow et al. Eur J Immunol 35:2081-2088, 2005), and plasmacytoid dendritic cells (Workman et al. J Immunol 182:18851891, 2009) that plays an important but incompletely understood role in the function of these lymphocyte subsets. In addition, the interaction between LAG-3 and its major ligand, Class II MHC, is thought to play a role in modulating dendritic

M.V. Goldberg

Johns Hopkins Kimmel Cancer Center, 1650 Orleans Street - CRB 423, Baltimore, MD 21231, USA

Johns Hopkins Kimmel Cancer Center, 1650 Orleans Street - CRB 410, Baltimore, MD 21231, USA

e-mail: [email protected]

G. Dranoff (ed.), Cancer Immunology and Immunotherapy, 269

Current Topics in Microbiology and Immunology 344, DOI 10.1007/82_2010_114 © Springer-Verlag Berlin Heidelberg 2011, published online: 18 November 2010

cell function (Andreae et al. J Immunol 168:3874-3880, 2002). Recent preclinical studies have documented a role for LAG-3 in CD8 T cell exhaustion (Blackburn et al. Nat Immunol 10:29-37, 2009), and blockade of the LAG-3/Class II interaction using a LAG-3 Ig fusion protein is being evaluated in a number of clinical trials in cancer patients. In this review, we will first discuss the basic structural and functional biology of LAG-3, followed by a review of preclinical and clinical data pertinent to a role for LAG-3 in cancer immunotherapy.

Keywords Anergy • CD4 lymphocyte • CD8 lymphocyte • Checkpoint • Tolerance • Treg • Tumor immunology • LAG-3

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment